The Shyft Group Appoints John Dunn as President and CEO
NOVI, Mich.–(BUSINESS WIRE)–The Shyft Group (NASDAQ: SHYF) (“Shyft” or “the Company”), the North American leader in specialty vehicle manufacturing,... Read more.
Embassy REIT Reports Strong Operating and Financial Results for 2Q FY2024: Delivers Record 2 Million Square Feet of Total Leases and Raises Leasing Guidance for FY2024
Highest ever quarterly leasing of 2 msf across 25 deals including 7 new deals over 100k sf Strengthens partnership with large global tech occupier for ~600k sf office... Read more.
Mithra and Searchlight Pharma Sign DONESTA® Licensing Agreement for Canada
Mithra to receive EUR 1.5 million milestone payout as a result of the signing of the agreement Additional licensing payout of EUR 15.55 million in regulatory and... Read more.
EMCOR Group, Inc. Reports Third Quarter 2023 Results
– Record Quarterly Revenues of $3.21 billion, 13.5% Increase Year-over-Year – – Record Quarterly Diluted Earnings per Share of $3.57, Non-GAAP... Read more.
Extensiv and Sendle Team Up to Lower the Cost of Small Parcel Delivery for 3PLs
In response to demand from its e-commerce customers, Extensiv adds Sendle to its Small Parcel Suite EL SEGUNDO, Calif. & SEATTLE–(BUSINESS WIRE)–#3PL—Extensiv... Read more.
Forward Air Corporation Provides Omni Transaction Update
GREENEVILLE, Tenn.–(BUSINESS WIRE)–Forward Air Corporation (NASDAQ: FWRD) (“Forward”) today provided an update on the previously announced transaction... Read more.
Sierra Space and NASA Prepare for Revolutionary Dream Chaser® Spaceplane’s Debut Mission to Space Station
LOUISVILLE, Colo.–(BUSINESS WIRE)–Sierra Space, a leading pureplay commercial space company building the first end-to-end business and technology platform... Read more.
MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business Update
NEW YORK–(BUSINESS WIRE)–$MNMD–Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage... Read more.
Cybin Announces Grant of European Patent Protecting its Proprietary Deuterated Programs
– European patent provides composition of matter and medical use protection for the Company’s proprietary deuterated psilocybin analog and deuterated DMT... Read more.
Precision BioSciences Presents Preclinical Data Highlighting Capabilities of ARCUS for Gene Insertion and Excision at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress
– ARCUS showed durable, high-efficiency gene insertion capabilities in NHPs and comparison to CRISPR-Cas9 – Data demonstrates ability of ARCUS to achieve... Read more.